Burlulipase has been used in trials studying the treatment of Lung Diseases, Cystic Fibrosis, Pancreatic Insufficiency, Digestive System Diseases, and Respiratory Tract Diseases.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.